Patricia M. Cameron
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Immune Response and Inflammation, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction
Most-Cited Works
- → Mediation by HLA-DM of dissociation of peptides from HLA-DR(1995)543 cited
- → Identification of a monocyte specific pre-interleukin 1 beta convertase activity.(1989)510 cited
- → Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzyme(1995)293 cited
- → Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitor(2002)268 cited
- → The envA Permeability/Cell Division Gene of Escherichia coli Encodes the Second Enzyme of Lipid A Biosynthesis(1995)190 cited
- → Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity(2003)182 cited
- → Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts.(1987)131 cited
- → Homogeneous Proximity Tyrosine Kinase Assays: Scintillation Proximity Assay versus Homogeneous Time-Resolved Fluorescence(1999)125 cited
- → Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form(1991)92 cited
- → A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.(1994)89 cited